High Court rules that Health Research Authority acted unlawfully over trial transparency

Posted:

August 2015

<p></p>

The British Medical Journal published a news article 1 on the Judicial Review to which Richmond responded by letter to the Editor 2.

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

View our latest peer-reviewed publications from a selection of our clinical trials.

Learn more about Richmond Pharmacology by viewing some of our videos.

21 - 23 September 2020

Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.

October 20, 2020

Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)

September 9, 2020

ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.

August 17, 2020

Richmond Pharmacology early phase drug development update.